To create a Detailed Project Report (DPR) for a Surgical Disposable Manufacturing Unit with ₹50 Crore Share Capital, we need to cover multiple sections including market potential, capacity, machinery, manpower, cost breakdown, and financials (ROI, break-even, profit projections, etc.).
Here’s a structured DPR Outline with estimated figures. You can customize it based on your product mix (syringes, gloves, gowns, masks, etc.).
Detailed Project Report (DPR) for Surgical Disposable Manufacturing Unit
Detailed Project Report (DPR) for Surgical Disposable Manufacturing Unit
1. Executive Summary
Project Name: MedProtect Surgical Disposables Pvt. Ltd.
Proposed Investment: ₹50 Crore (Equity Share Capital)
Location: Industrial Area (SEZ or Medical Device Park preferred)
Capacity: 100 million units/year (gloves, masks, syringes, gowns)
Target Market: India & Export (Asia, Africa, Middle East)
Project Duration: 18 months (setup to commercial production)
—
2. Business Overview
Growing demand for sterile and disposable medical products.
Rising awareness post-pandemic.
Compliance with ISO 13485, CE, and US FDA standards ensures global competitiveness.
—
3. Product Portfolio
Surgical Gloves (Latex & Nitrile)
3-Ply and N95 Masks
Disposable Gowns & Drapes
Syringes (2ml to 10ml)
IV Cannulas & Blood Collection Tubes
—
4. Manufacturing Capacity & Plant Requirements
Product Annual Capacity Machinery Cost (₹ Cr)
Surgical Gloves 30 Million Pairs 12
Surgical Masks 25 Million Units 5
Gowns & Drapes 5 Million Units 6
Syringes 30 Million Units 10
Others 10 Million Units 4
Total – ₹37 Cr
—
5. Land, Building & Infrastructure
Item Cost (₹ Cr)
Land (5–7 acres) 5
Building (50,000 sqft) 7
Utilities (Power, HVAC, ETP) 3
Total ₹15 Cr
—
6. Manpower Requirements
Category Nos Annual Cost (₹ Cr)
Technical Staff 50 2.5
Labor 100 2.0
Admin & Marketing 30 1.5
Total 180 ₹6 Cr/year
—
7. Raw Material & Operating Cost (Annual)
Item Cost (₹ Cr)
Latex/Nitrile 8
Non-Woven Fabric 6
Plastic Resin 6
Packaging Material 2
Utilities (Power, Water) 2
Maintenance, QC 2
Total OPEX ₹26 Cr
—
8. Sales & Revenue Projections
Product Volume (Units) Selling Price Revenue (₹ Cr)
Gloves 30M Pairs ₹7 21
Masks 25M Units ₹3 7.5
Gowns & Drapes 5M Units ₹30 15
Syringes 30M Units ₹3 9
Other Products 10M Units ₹4 4
Total Revenue – – ₹56.5 Cr
—
9. Profit & Loss Estimate (Year 1–3)
Particulars Year 1 Year 2 Year 3
Revenue (₹ Cr) 40 55 65
Operating Cost (₹ Cr) 30 33 36
EBITDA (₹ Cr) 10 22 29
Net Profit (₹ Cr) 6 15 21
PAT Margin (%) 15% 27% 32%
—
10. Return on Investment (ROI) & Break-Even
Break-even Period: ~2.5 years
ROI by Year 3: ~40%
IRR (5-Year): ~28–30%
—
11. Compliance & Certifications
ISO 13485 for medical device quality systems.
CE Marking for export.
CDSCO, BIS certification for India.
—
12. Risk Factors & Mitigation
Raw material price volatility – Long-term supply contracts.
Regulatory delays – Experienced legal/regulatory advisors.
Market saturation – Focus on exports and high-quality differentiation.
—
13. Funding Structure
Source Amount (₹ Cr)
Equity Share Capital 50
Bank Loan (optional) 10
Total Funding ₹50–60 Cr